References
DePaula AL, Macedo ALV, Schraibman V, Mota BR, Vencio S (2009) Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34. Surg Endosc 23:1724–1732
Rubino F, Gagner M (2002) Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 236(5):554–559
Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240(2):236–242
Mason EE (1999) Ileal (correction of ileal) transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 9(3):223–228
Gagner M (2005) La transposition ileale avec ou sans gastrectomie par laparoscopie chez l’homme (TIG): la troisieme generation de chirurgie bariatrique. J Coeliochirurgie 54:4–10
Almahmeed T, Pomp A, Gagner M (2006) Laparoscopic reversal of biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis 2(4):468–471
Boza C, Gagner M, Devaud N, Escalona A, Muñoz R, Gandarillas M (2008) Laparoscopic sleeve gastrectomy with ileal transposition (SGIT): a new surgical procedure as effective as gastric bypass for weight control in a porcine model. Surg Endosc 22(4):1029–1034 [Epub 2008 Feb 13]
Boza C, Gagner M, Yung E, Milone L (2007) S.G.I.T.: sleeve gastrectomy with ileal transposition: weight progression and metabolic impact in obese Zucker rats. Abstract, Digestive Disease Week, Society for Surgery of the Alimentary tract, 48th annual meeting, May 19–21, 2007, Washington, DC
Scopinaro N, Papadia F, Marinari G, Camerini G, Adami G (2007) Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion with BMI < 35 kg/m2. Obes Surg 17(2):185–192
Kotidis EV, Koliakos G, Papavramidis TS, Papavramidis ST (2006) The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to weight-reducing effect of this procedure? Obes Surg 16(5):554–559
Vidal J, Ibarzabal A, Romero F, Delgado S, Momblan D, Flores L, Lacy A (2008) Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 18(9):1077–1082
Disclosures
Dr. Gagner has equity interest in and is a consultant for EMS; he is a consultant to and has received honoraria from Gore, Olympus, and Covidien; he is a consultant to Synovis and Karl Storz; and he has received honoraria from Cine-Med, Ethicon Endosurgery, and Bariatric Times.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gagner, M. Surgical treatment of nonseverely obese patients with type 2 diabetes mellitus: sleeve gastrectomy with ileal transposition (SGIT) is the same as the neuroendocrine brake (NEB) procedure or ileal interposition associated with sleeve gastrectomy (II-SG), but ileal interposition with diverted sleeve gastrectomy (II-DSG) is the same as duodenal switch. Surg Endosc 25, 655–656 (2011). https://doi.org/10.1007/s00464-010-1221-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-010-1221-9